We compared the formation of I4CO2 from [I-I4C]fatty acids in homogenates of cultured skin fibroblasts and white blood cells from 25 patients with adrenoleukodystrophy (ALD) and from 24 controls. The ALD group included 16 boys with childhood ALD, five men with adrenomyeloneuropathy (AMN), and two boys and two girls with neonatal ALD. The substrates were unbranched saturated fatty acids ranging in chain length from 16-26 carbons. From C24:0, the radioactive C 0 2 production by homogenates of ALD fibroblasts and white blood cells was 17% and 37% of control, respectively, and from C26:O it was 17% of control in ALD fibroblasts. The C 0 2 evolution from palmitate (C16:O) in the ALD was identical to the control group; for C18:0, the value for ALD cells was 76% of control, and fatty acids with chain lengths between C18:O and C24:O gave intermediate results.
Summary
We compared the formation of I4CO2 from [I-I4C]fatty acids in homogenates of cultured skin fibroblasts and white blood cells from 25 patients with adrenoleukodystrophy (ALD) and from 24 controls. The ALD group included 16 boys with childhood ALD, five men with adrenomyeloneuropathy (AMN), and two boys and two girls with neonatal ALD. The substrates were unbranched saturated fatty acids ranging in chain length from 16-26 carbons. From C24:0, the radioactive C 0 2 production by homogenates of ALD fibroblasts and white blood cells was 17% and 37% of control, respectively, and from C26:O it was 17% of control in ALD fibroblasts. The C 0 2 evolution from palmitate (C16:O) in the ALD was identical to the control group; for C18:0, the value for ALD cells was 76% of control, and fatty acids with chain lengths between C18:O and C24:O gave intermediate results.
Results for childhood ALD patients were similar to those for the AMN patients. More limited studies with cultured amniocytes of fetuses with childhood ALD gave results similar to those obtained with cultured skin fibroblasts, and results with neonatal ALD patients appeared to be the same as for childhood ALD and AMN. Studies of three women who were carriers for childhood ALD gave values intermediate between ALD and control. The total C26:O levels in ALD cultured skin fibroblasts and white blood cells were 4-6 times that of control; the total C24:O levels were increased 10-30%, whereas the C22:O levels were unchanged.
The results suggest that ALD patients have a defect in the oxidation of very long chain fatty acids (C24:O and longer) but not for the degradation of fatty acids with a chain length of 18 carbons or less. Such a defect could account for the accumulation of the very long chain fatty acids in a variety of tissues and lipid moieties. The accumulation of these fatty acids, coupled with the metabolic data presented here, suggests that normal catabolism of very long chain fatty acids involves a metabolic pathway which is distinct from that for other fatty acids, and that this pathway is genetically deficient in patients with ALD. Abbreviations ALD, adrenoleukodystrophy AMN, adrenomyeloneuropathy C22:0, docosanoic acid (behenic acid) C24:0, tetracosanoic acid (lignoceric acid) C26:0, hexacosanoic acid (cerotic acid) C27:0, heptacosanoic acid GLC, gas liquid chromatography WBC, white blood cell ALD is a genetically-determined, progressive disorder which affects mainly the adrenal cortex and the white matter of the nervous system (32) . It is associated with the accumulation of saturated very long chain fatty acids (mainly C26:0, C25:0, and C24:O) in the cholesterol esters and gangliosides in these tissues (1 1, 17, 30) . Accumulation of these same fatty acids has also been reported in sphingomyelin and other lipid moieties of plasma (23) and red blood cells (38) and in cultured skin fibroblasts (22) , cultured muscle cells (I), and cultured amniocytes (24) .
Several types of ALD have been described. The most common type is the childhood form (32) that usually presents between age 4 and 8 years, involves mainly the cerebral white matter and adrenal cortex, and leads to death during the first or second, decade. Pedigree analysis is consistent with X-linked mode of inheritance (32) . This has been confirmed by studies with cultured skin fibroblasts and the ALD gene has been mapped to Xq28 (19) . AMN, another type of ALD, occurs mainly in adults, progresses more slowly, and in addition to adrenal cortex involves mainly the white matter of the spinal cord and peripheral nerves (8) . ALD and AMN have been described in the same kindred (4) and it is considered likely that ALD and AMN represent different forms of the same disease process. Recent interest has been focused on a new entity referred to as connatal or neonatal adrenoleukodystrophy (2, 3, 9, 12, 16, 21, 38) . This early onset disorder shows the same degree of accumulation of very long chain fatty acids as childhood ALD and AMN, but differs from them in that it involves a wider range of tissues. Furthermore, neonatal-connatal ALD involves girls as frequently and as severely as it does boys, and there is circumstantial evidence that it is inherited as an autosomal recessive trait (9, 12) .
The enzymatic basis for the accumulation of very long chain fatty acids in ALD is unknown. Because the very long chain fatty acid excess in brain and adrenal cortex is present most strikingly in the cholesterol ester fraction, initial enzymatic studies focused on cholesterol esterases. No abnormalities were detected (1 8,27).
We now report impaired oxidation of very long chain fatty acids in homogenates of white blood cells, and cultured skin fibroblasts and amniocytes from patients with childhood ALD, AMN, and neonatal ALD. Some of the results with cultured skin fibroblasts have been reported previously (33) and the data with white blood cells have been presented as an abstract (34) .
MATERIALS AND METHODS

Patients.
We studied 16 boys with childhood ALD (age, 4-16 yr) and five men with AMN (age, 18-50 yr). The neonatal ALD cases included two boys, age 2 (12) and 9 yr (3); and two girls, age 2 (12) and 8 yr (21) . All of the patients showed the characteristic clinical features as well as elevated levels of very long chain fatty acids in plasma (23) and cultured skin fibroblasts (22) . The ALD cultured amniocytes were derived from male fetuses at risk for childhood ALD, in whom the diagnosis was confirmed by postmortem studies of fetal tissues after induced abortion (24) . Control cells were derived from 20 normal men and women age 12-30 yr, and from four patients with sphingolipidoses (Farber's disease, metachromatic leukodystrophy, globoid leukodystrophy, and Fabry's disease).
Materials. [l-'4C]Palmitic and [l-14C]stearic acids and KI4CN were purchased from New England Nuclear, Boston, MA. Other [l-14C]labeled fatty acids were synthesized according to the procedure described previously (10, 26) . ATP, CoASH, and NAD were obtained from PL-Biochemicals, Milwaukee, WI and malate, FAD, and alpha-cyclodextrin from Sigma Chemical Co., St. Louis, MO. L-Carnitine was a gift of Dr. Yuzo Kawashima, Otsuka Pharmaceutical Co., Tokushima, Japan.
Isolation of white blood cells. Ten milliliters of heparinized blood was mixed with 5 ml of 6% dextran, 3.5 ml of 5% glucose, and 1.5 ml of ACD solution (2.45% glucose, 2.2% sodium citrate dihydrate, and 0.73% citric acid) and allowed to stand for 30-40 min at room temperature or until the red blood cells had settled out. The upper layer was removed by suction and centrifuged at 350 x g for 15 min. The supernatant fraction was discarded and the residual red cells in the pellet were lysed by the addition of hypotonic sodium chloride solution for 2 min before being returned to isotonic saline. The leukocytes were then collected by centrifugation.
Cultured skin fibroblasts and amniocytes. Fibroblasts were grown in a 5% carbon dioxide atmosphere at 37°C in Eagle's minimum essential medium plus Earle's salts and 13% fetal calf serum. The cells were harvested 3-4 d after confluence, treated with 0.2% trypsin, and centrifuged. The amniocytes were prepared in the same way except that 15% fetal calf serum was used.
Preparation of homogenates. Cells were homogenized by 20 passes with a hand-driven Teflon coated glass homogenizer in 0.06% sodium chloride.
Enzyme assay. The reaction mixture contained 12 micromolar [1-I4C]fatty acid (approximately 6 x lo5 dpm) coated on Celite, 20 mM MOPS-HCl buffer, pH 7.0, 30 mM KCl, 1 mM MgC12, 8.5 mM ATP, 0.25 mM NAD, 0.17 mM FAD, 0.5 mM malate, 2.5 mM L-carnitine, 0.08 mM CoASH, and 1 mg of alphacyclodextrin in a total volume of 0.6 ml. The reaction was started by addition of the cell homogenates containing 200-500 pg of protein. The mixture was incubated at 37°C for 1 h in a side arm test tube. The reaction was stopped by the addition of 0.25 ml of 3 N H2S04 from the side arm tube and the radioactivity was collected in a glass fiber filter hanging from the top and measured as described previously (25) . We showed previously that CO2 evolution in homogenates of ALD and control fibroblasts was linear with time up to 80 min, and with protein concentration up to 400 pg (33) .
Proteins were measured by the procedure of Miller (20) with bovine serum albumin as the standard. Fatty acids were quantitated by capillary gas liquid chromatography (23) . Figure 1 shows that production of I4CO2 from [l-14C]labeled very long chain fatty acids is significantly reduced in homogenates of ALD cultured skin fibroblasts or white blood cells. The differences are most striking for C24:0, where the C02 production was 16% and 37% of control for fibroblasts and white blood cells, respectively, and the differences are statistically significant with P values of less than 0.00 1. For C26:O the value was 17% of control in fibroblasts but, probably due to the smaller number of samples tested statistical significance was only at the 0.05 Almost all of the tests were done in duplicate. In several instances repeat sets of analyses were done on samples from the same patient. The results for childhood adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) patients are grouped together. There was no apparent difference between them. The differences between ALD and controls for C24:O oxidation in both fibroblasts and plasma are statistically significant (P < 0.001). Abbreviations: FIB, fibroblasts and WBC, white blood cells.
RESULTS
level. In contrast, COz production from [1-14C]C16:0 in ALD fibroblasts was identical to control, and only insignificantly increased over control in the white blood cells. C02 production from C18:O in ALD fibroblasts was 76% of control, and this difference was not statistically significant. The results were similar regardless of whether they were obtained from childhood ALD or AMN patients (data not shown), and limited studies with four patients with neonatal ALD suggest that results are similar to those in childhood ALD and AMN. Figure 2 shows the ratios between 14C02 production from [ l -14C]C16:0 and [l-14C]C24:0. Use of this ratio may reduce variations attributable to differences in homogenization or other experimental conditions. For ALD cultured skin fibroblasts and white blood cells, respectively, this ratio is 4.1 and 3.2 times control. Both differences are statistically significant. For white blood cells the P value was less than 0.00 1 whereas for fibroblasts it was less than 0.0 1. Limited data with ALD cultured amniocytes suggest that results with these cells are equivalent to those with cultured skin fibroblasts. Studies with white blood cells from three women who are obligate heterozygotes for X-linked ALD gave C16:O/C24:0 ratios intermediate (29.6 & 5) between control (1 8.5 + 2.7) and the ALD hemizygote (41.9 2 10). Because the observed differences of fatty acid oxidation may be related to dilution of exogenous substrates by excess of very long chain fatty acids in ALD cells, we measured the levels of these fatty acids in cultured skin fibroblasts and white blood cells (Table I) . As reported previously (22, 23) , the level of C22:O was unaltered whereas the level of C26:O in fibroblasts and white blood cells respectively was increased to 5.5 and 4.1 times control. In contrast, the C24:O level was increased only 1 1-30% over control. This finding makes it unlikely that the reduced COz production from C24:O is due to dilution of the radioactive exogenous substrate by C24:O contained within the tissue sample. In addition, the quantity of exogenous C24:O (6 nmole per tube) was relatively large in comparison to the total amount of endogenous C24:O (0.6-1 nmole per tube). DISCUSSION I4CO2 production from [1-14C]C24:0 and [1-'4C]C26:0 is reduced significantly in ALD cultured skin fibroblasts, white blood cells, and amniocytes whereas COz production from C16:O is normal. This finding suggests that there is a specific impairment in the oxidation of very long chain fatty acids in ALD, which may account for the tissue accumulation of these substances that is a characteristic of this disorder. Previously reported experiments in which ALD and control fibroblast homogenates were mixed, had ruled out the presence of inhibitors or activators (33) . The defect appears to be present in childhood ALD, AMN, and neonatal ALD. This does not necessarily imply, however, that these disorders have the same metabolic basis because COz formation from fatty acids requires a large number of separate metabolic steps, and our present studies provide no information about which of these steps is involved. (15) or beta-oxidation mechanism. Alpha-oxidation is utilized for the synthesis of odd chain and alpha-hydroxy fatty acids. Because these substances are present in normal concentrations in ALD tissues, we consider it unlikely that the ALD oxidative defect involves alpha-oxidation.
There are at least three systems for the beta-oxidation of fatty acids. First is the well known mitochondrial system (7); second, the more recently described peroxisomal system (14, 28) ; and third, a system for C24:O which appears to be specific for brain tissue (37) . We consider it unlikely that this last system is involved in ALD because the tissue accumulation of very long chain fatty acids is widespread and in this report we demonstrated that the ALD oxidative defect is present in tissues other than brain.
It is our current hypothesis that the ALD metabolic defect may involve a peroxisomal beta-oxidation system. We favor this hypothesis because I) long chain fatty acids are known to be oxidized in peroxisomes (14) ; 2) we presented evidence that the oxidation of C24:O in rat liver takes place in peroxisomes (1 3); 3) we recently showed that patients with the Zellweger cerebrohepatorenal syndrome have elevated levels of very long chain fatty acid levels (3) and impaired I4CO2 production from [l-I4C] C24:O (Singh, I. unpublished observation) similar to observations in ALD; and 4) patients with the Zellweger syndrome lack peroxisomes (6, 29, 39) . Definition of the metabolic defect in ALD will require study of specified subcellular fractions, and analysis of the separate steps involved in fatty acid degradation. It is a point of challenge and interest that the abnormalities in ALD demonstrated so far suggest that normally there exists a hitherto unrecognized separate system for the degradation of saturated very long chain fatty acids. We believe that it is a component of this system which is genetically deficient in ALD.
